Takgene Biopharma

Takgene Biopharma is a prominent biotechnology company based in Iran, specializing in the research, development, and large-scale production of probiotics, industrial enzymes, and recombinant therapeutic proteins. Founded in 2012, the company has established itself as a regional leader in biomanufacturing, operating advanced GMP-certified facilities for microbial fermentation. Their portfolio includes high-profile biopharmaceuticals such as Interferon beta-1a (Recigen) for the treatment of multiple sclerosis, alongside an extensive line of human and animal probiotics. In addition to its own product pipeline, Takgene provides contract manufacturing and development services (CDMO) to domestic and international partners in the life sciences sector.